April, 2008: Actavis, maker of the prescription drug DIGITEK, launched a Class I nationwide recall of the drug in April 2008. Digitek pills were made for an unknown period of time with a potentially fatal defect. Some tablets may have been twice as thick as they were supposed to be. That meant they could contain twice the approved level of Digitalis, the active ingredient in Digitek, leading to Digitalis toxicity. More information on Digitek recall.